STAT+: Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid

“That idea of a pediatrician as not just a doctor, but an advocate, solidified in my mind as a young person. I can’t actually remember wanting to be anything else,”… […]

Bristol Myers Squibb has agreed to pay up to $11 million to settle a lawsuit that accused several drugmakers of conspiring to block generic competition to HIV medicines. […]

Nearly 70% of biotech insiders say financing — such as raising venture capital or launching an IPO — will be a challenge in 2023. […]